BlackRock’s Zymergen Inc. Common Stock ZY Stock Holding History

BlackRock’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-933,154	Closed	-$2.6M	–	5975
2022 Q3	$2.6M	Buy	933,154 +511,943	+122%	+$1.24M	﹤0.01%	4060
2022 Q2	$519K	Sell	421,211 -3,771,583	-90%	-$6.32M	﹤0.01%	4766
2022 Q1	$12.1M	Buy	4,192,794 +58,103	+1%	+$247K	﹤0.01%	3474
2021 Q4	$27.7M	Buy	4,134,691 +2,941,214	+246%	+$28.6M	﹤0.01%	3068
2021 Q3	$15.7M	Sell	1,193,477 -7,082	-0.6%	-$150K	﹤0.01%	3436
2021 Q2	$48M	Buy	+1,200,559	New	+$47.4M	﹤0.01%	2729

BlackRock's ZY Position: Q4 2022 in Review

BlackRock sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 933,154 shares — an estimated $2.6M sold.

BlackRock first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $48M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

BlackRock reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
BlackRock sold 933,154 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $2.6M.
BlackRock first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
BlackRock's Zymergen Inc. Common Stock position peaked at $48M in Q2 2021.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on BlackRock's 13F filing for Q4 2022, filed 13 Feb 2023.